Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
INmune Bio and Quantum Computing Inc. have partnered to apply quantum optimization and AI to advance Alzheimer’s drug research using INmune Bio’s XPro1595.
Cizzle Brands Corporation has commenced an underwritten public offering in the U.S., aiming to list its shares on a national securities exchange under the symbol 'CZZL'.
SeaStar Medical’s Chief Medical Officer, Col. (Ret.) Kevin Chung, MD, received the 2026 Combat Nephrology Award at the Update in Critical Care Nephrology meeting in Madrid, Spain.
TruGolf Links has engaged Polymath to tokenize its capitalization table on Polymesh, six days after TruGolf's acquisition of Polymath on October 8, 2026.
Vir Biotechnology and Gilead Sciences have entered a multi-program collaboration to develop three novel PRO-XTEN® dual-masked T-cell engagers (TCEs) for solid tumors.
Sarepta presented preclinical data at the 2026 Oligonucleotide Therapeutics Society Annual Meeting showing SRP-1003 achieved up to 80% knockdown of pathogenic DMPK RNA in both nuclear and cytoplasmic compartments.
Propanc Biopharma published a peer-reviewed pilot study in Scientific Reports demonstrating PRP's anti-tumor efficacy in pancreatic and ovarian cancer models.